Skip to content
MarketScale
‹ Back to IndustriesHealthcare

International Women’s Month

International Women’s Month, celebrated annually in March, is a time dedicated to honoring and recognizing the achievements and contributions of women throughout history and across various fields. It is a global observance that seeks to raise awareness about gender equality and women’s rights, while also promoting the empowerment and advancement of women worldwide. During International…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
International Women’s Month

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

International Women’s Month, celebrated annually in March, is a time dedicated to honoring and recognizing the achievements and contributions of women throughout history and across various fields. It is a global observance that seeks to raise awareness about gender equality and women’s rights, while also promoting the empowerment and advancement of women worldwide.

During International Women’s Month, numerous events, campaigns, and initiatives take place to highlight the social, economic, cultural, and political achievements of women. It is a time to celebrate women’s accomplishments and their vital roles in society. The month provides an opportunity to reflect on the progress made in advancing gender equality and to acknowledge the work that still needs to be done.

One of the key focuses of International Women’s Month is to address the various challenges that women face, such as discrimination, gender-based violence, unequal access to education and healthcare, and limited opportunities for economic and political participation. It serves as a platform for advocacy and activism, aiming to drive positive change and foster a more inclusive and equitable world.

During this month, individuals and organizations are encouraged to engage in activities that promote gender equality and support women’s empowerment. These activities may include organizing conferences, seminars, workshops, and panel discussions centered around women’s issues. They may also involve highlighting the achievements of women in various fields, promoting women-owned businesses, showcasing women artists and creators, and supporting women’s rights organizations.

International Women’s Month serves as a reminder of the importance of equal rights and opportunities for women, not just during the designated month but throughout the year. It encourages everyone to contribute to the advancement of gender equality in their respective spheres of influence and to work collectively towards a more inclusive and just society. By recognizing and celebrating women’s achievements, International Women’s Month aims to inspire future generations of women and girls to pursue their dreams and aspirations without limitations.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512